fda compounding glp-1 enforcement news today Crackdown GLP-1 Drugs: Brand Companies Push

Spinal stenosis is a narrowing of the spaces within your spine, which puts pressure on the nerves, leading to pain and discomfort

Gastrointestinal adverse events leading to treatment discontinuation occur in approximately 4-5% of patients on Wegovy, with diarrhea being one contributing factor

These therapies have a central role in improving glycemic control and reducing cardiovascular risk

(Figure 4)

No Significant Increase in Heart Failure Risk: Concerns regarding an increase in heart failure with saxagliptin, and to a lesser extent alogliptin, resulted in no use or cautious use of these agents in patients with cardiac backgrounds